CHARLES E. HARRIS
Chairman of the Board and Chief Executive Officer since 1984
Prior to 1984, Mr. Harris had an 18 year career in the investment industry, including serving as Chairman of Wood, Struthers and Winthrop Management Corp., the investment advisory subsidiary of Donaldson, Lufkin & Jenrette. He is a past Trustee and current Co-Chairman of the President’s Council of Cold Spring Harbor Laboratory, a research and education institution in molecular biology and genetics, and a current Trustee and Chairman of the audit committee of Nidus Center, a life sciences business incubator. He is a life-sustaining fellow of the Massachusetts Institute of Technology and a Shareholder of its Entrepreneurship Center. Mr. Harris was a member of the Advisory Panel for the Congressional Office of Technology Assessment. He was graduated from Princeton University (A.B.) and the Columbia University Graduate School of Business (M.B.A.).
W. DILLAWAY AYRES, JR.
Director since 2006
Mr. Ayres is Chief Operating Officer of Cold Spring Harbor Laboratory, a research and educational institution in the biological sciences since November 2000. Prior to joining Cold Spring Harbor Laboratory in 1998, Mr. Ayres had a 20-year business career during which he worked as a corporate executive, investment banker and entrepreneur. In 1996, he co-founded Business & Trade Network, Inc., a business-to-business, venture capital-backed internet company. Prior to that he worked for five years as a Managing Director of Veronis, Suhler & Associates, a boutique investment banking firm in New York specializing in the media/communications industry. At Veronis, Suhler, he focused on investing the firms's private equity fund. He was graduated from Princeton University with an A.B. degree in English and from Columbia University Graduate Shcool of Business with an M.B.A.
C. WAYNE BARDIN, M.D.
Director since 1994
Dr. Bardin is President of Bardin LLC, a consulting firm to pharmaceutical companies. From 1998 to 2003, he served as President of Thyreos Corp., a privately held, start-up pharmaceutical company. From 1978 through 1996, he was Vice President of The Population Council, an international non-profit organization focusing on population issues. He has held appointments as Professor of Medicine, Chief of the Division of Endocrinology, The Milton S. Hershey Medical Center of Pennsylvania State University, and Senior Investigator, Endocrinology Branch, National Cancer Institute. He has directed basic and clinical research leading to over 500 publications and patents. He has also served as a consultant to several pharmaceutical companies. He has been appointed to the editorial boards of 15 journals. He has served on committees and boards for the National Institute of Health, World Health Organization, The Ford Foundation, and various scientific societies. He received a B.A. from Rice University, M.S. and M.D. degrees from Baylor University and holds honorary degrees from the University of Caen, the University of Paris, and the University of Helsinki.
PHILLIP A. BAUMAN, M.D.
Director since 1998
Dr. Bauman is a practicing orthopedic surgeon. He has been Senior Attending in Orthopedic Surgery at St. Luke's/Roosevelt Hospital Center in Manhattan since 1999 and has served as an elected member of the Executive Committee of the Medical Board since 2000. He has been on the Board of Managers for the Hudson Crossing Surgery Center since 2005. He has been Assistant Professor of Orthopedic Surgery at Columbia University since 1997 and a Vice President of Orthopedic Associates of New York since 1994. He was elected a fellow of the American Academy of Orthopaedic Surgeons in 1991. He is an active member of the American Orthopaedic Society for Sports Medicine, the New York State Society of Orthopaedic Surgeons and the American Medical Association. He received B.A. and M.A. degrees in Biology from Harvard University and an M.D. degree from Columbia University.
G. MORGAN BROWNE
Director since 1992
Mr. Browne is President since 2004 and a Trustee since 2000 of Planting Fields Foundation, a historic estate arboretum. From 2001 to 2003, he served as Chief Financial Officer of Cold Spring Harbor Laboratory, a private, not-for-profit research and education institution in molecular biology and genetics; he was its Administrative Director from 1985-2000. In prior years, he was active in the management of numerous scientifically based companies as an officer, as an individual consultant and as an associate of Laurent Oppenheim Associates, Industrial Management Consultants. Mr. Browne is a director of OSI Pharmaceuticals, Inc. (a publicly held company principally engaged in drug discovery based on gene transcription). He is also a Director of Evinu Corporation, a start-up company developing nutraceuticals. He was a founding Director of the New York Biotechnology Association and a founding Director of the Long Island Research Institute. He is a graduate of Yale University.
DUGALD A. FLETCHER
Director since 1996
Mr. Fletcher is President of Fletcher & Company, Inc., a management consulting firm since 1984. Until the end of 1997, he was Chairman of Binnings Building Products Company, Inc. His previous business appointments include: adviser to Gabelli/Rosenthal LP, a leveraged buyout fund; Chairman of Keller Industries, building and consumer products; Senior Vice President of Booz-Allen & Hamilton; President of Booz-Allen Acquisition Services; Executive Vice President and a Director of Paine Webber, Inc.; and President of Baker, Weeks and Co., Inc., a New York Stock Exchange member firm. He is currently a Trustee of the Gabelli Growth Fund and a Director of the Gabelli Convertible and Income Securities Fund, Inc.. He was graduated from Harvard College and Harvard Business School (M.B.A.).
DOUGLAS W. JAMISON
Director since 2007
Prior to joining Harris & Harris Group, Mr. Jamison worked for five years as a Senior Technology Manager at the University of Utah Technology Transfer Office, where he managed intellectual property for the University of Utah. This included assessing technologies in both the biological sciences and the physical sciences, working with patent attorneys to develop patent protection, and developing and marketing these technologies with industry. He was graduated from Dartmouth College (B.A.) and the University of Utah (M.S.).
KELLY S. KIRKPATRICK, PH.D.
Director since 2002
Dr. Kirkpatrick has served as a consultant to Harris & Harris Group on nanotechnology and in our due diligence work on certain prospective investments. She is an independent business consultant assessing and advising on early stage, technology start-ups for venture captial companies. From 2000 to 2002, she served in the Office of the Executive Vice Provost of Columbia University as Director of the Columbia University Nanotechnology Initiative and as Director for Research and Technology Initiatives. From 1998 to 2000, she served in the White House Office of Science and Technology Policy as a Senior Policy Analyst involved in the National Nanotechnology Initiative. From 1997 to 1998, she was a Science Policy Coordinator for Sandia National Laboratories. From 1995 to 1996, she served in the office of Senator Joseph Lieberman as a Legislative Assistant, Congressional Science and Engineering Fellow. She holds a Ph.D. degree from Northwestern University in Materials Science and Engineering.
LORI D. PRESSMAN
Director since 2002
Ms. Pressman has served as a consultant to Harris & Harris Group on tiny technology, intellectual property and in our due diligence work on certain prospective investments. She also acts as an observer for us at board meetings of certain portfolio companies in the Boston area. She is a business consultant providing advisory services to start-ups and venture capital companies. She consults internationally on technology transfer practices and metrics for non-profit and government organizations. From 1999 to 2001, she was Chair of the Survey Statistics and Metrics Committee of the Association of University Technology Managers. From 1989 until 2000, she was employed by the Massachusetts Institute of Technology in the Technology Licensing Office, serving as Technology Licensing Officer from 1989 to 1995 and Assistant Director from 1996 to 2000. She has previously been Senior Development Engineer at Lasertron, Inc., and a Member of the Solid State Materials Research Laboratory at Bell Laboratories. She holds an S.B. degree in Physics from the Massachusetts Institute of Technology and an M.S.E.E. from the Columbia School of Engineering.
CHARLES E. RAMSEY
Director since 2002
Mr. Ramsey has been a consultant since 1997. He is a retired founder and principal of Ramsey/Beirne Associates, Inc., an executive search firm that specialized in recruiting top officers for high-technology companies, many of which were backed by venture capital. He works on construction projects in Nicaragua as a member of the Nicaraguan Initiative Committee for the Presbyterian Churches of the Hudson River and Chairman of Bridges to Community, an non-governmental organization dedicated to construction projects in Nicaragua. He is a graduate of Wittenberg University.
JAMES E. ROBERTS
Director since 1995
Mr. Roberts is President of AequiCap Insurance Company. He is also a senior office of various other AequipCap affiliated entities. From 2002 to 2005, he was Executive Vice President and Chief Underwriting Officer of the Reinsurance Division of Alea North America Company and Senior Vice President of Alea North American Insurance Company. From 1999 to 2002, he was Chairman and Chief Executive Officer of The Insurance Company of New York, Dakota Specialty Insurance Company, and ReCor Insurance Company Inc., all members of Trenwick Group, Ltd. Mr. Roberts has held senior executive positions with other companies in the Trenwick Group. Mr. Roberts is a graduate of Cornell University (A.B.).
RICHARD P. SHANLEY
Director since 2007
Mr. Shanley is a retired Partner of Deloitte & Touche LLP (2001 to 2006). He worked for Eisner LLP from 1976 to 2001. During his over 30 years of public accounting experience, he served as lead audit partner on numerous audit engagements for public and private companies and companies making public stock offerings, including those requiring application of Sarbanes-Oxley Section 404. He served as lead audit partner primarily for biotech, pharmaceutical and high-tech companies, including companies enabled by nanotechnology. He has been actively involved on the Biotech Council of New Jersey, the New Jersey Technology Council, the New York Biotechnology Association, the Connecticut Venture Group, the Biotechnology Industry Organization and the NanoBusiness Alliance. He is an active member of the New York State Society of Certified Public Accountants and the American Institute of Certified Public Accountants. He is currently serving his third term on the New York State Society of CPA's Professional Ethics Committee. He is a licensed Certified Public Accountant in New Jersey and New York. He was graduated from Fordham University (B.S.) and Long Island University (M.B.A. in Accounting).